Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (9)
P 4 (1)

Trial Status

Withdrawn4
Completed4
Terminated1
Recruiting1
Unknown1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline